Baojian Qi

Title: Innovations of Baojian Qi in Pharmaceutical Development

Introduction

Baojian Qi is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target androgen receptors. With a total of 3 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

One of his latest patents is a method for preparing a protein degradation agent compound. This invention specifically addresses the degradation of androgen receptors (AR) using a compound represented by a specific formula and its pharmacologically acceptable salts. Another notable patent involves a phthalazinone compound, detailing both its preparation method and medical applications. This compound is also aimed at degrading androgen receptors, showcasing Qi's focus on innovative solutions in hormone-related therapies.

Career Highlights

Throughout his career, Baojian Qi has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Shanghai Jemincare Pharmaceuticals Co., Ltd. and Jiangxi Jemincare Group Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

In his professional journey, Baojian Qi has collaborated with notable colleagues, including Hongfu Lu and Weiqiang Xing. These partnerships have likely contributed to his success in developing groundbreaking pharmaceutical solutions.

Conclusion

Baojian Qi's innovative work in the pharmaceutical sector, particularly in the development of compounds targeting androgen receptors, highlights his significant contributions to medical science. His patents and collaborations reflect a commitment to advancing healthcare through innovative solutions.